BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun D, Li YC, Zhang XY. Lidocaine Promoted Ferroptosis by Targeting miR-382-5p /SLC7A11 Axis in Ovarian and Breast Cancer. Front Pharmacol 2021;12:681223. [PMID: 34122108 DOI: 10.3389/fphar.2021.681223] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Yin J, Lin Y, Fang W, Zhang X, Wei J, Hu G, Liu P, Niu J, Guo J, Zhen Y, Li J. Tetrandrine Citrate Suppresses Breast Cancer via Depletion of Glutathione Peroxidase 4 and Activation of Nuclear Receptor Coactivator 4-Mediated Ferritinophagy. Front Pharmacol 2022;13:820593. [DOI: 10.3389/fphar.2022.820593] [Reference Citation Analysis]
2 Lin HY, Ho HW, Chang YH, Wei CJ, Chu PY. The Evolving Role of Ferroptosis in Breast Cancer: Translational Implications Present and Future. Cancers (Basel) 2021;13:4576. [PMID: 34572802 DOI: 10.3390/cancers13184576] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jiang M, Hu R, Yu R, Tang Y, Li J. A narrative review of mechanisms of ferroptosis in cancer: new challenges and opportunities. Ann Transl Med 2021;9:1599. [PMID: 34790805 DOI: 10.21037/atm-21-4863] [Reference Citation Analysis]
4 Yi C, Yu AM. MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells. Front Mol Biosci 2022;9:893846. [PMID: 35755805 DOI: 10.3389/fmolb.2022.893846] [Reference Citation Analysis]
5 Wu S, Zhu C, Tang D, Dou QP, Shen J, Chen X. The role of ferroptosis in lung cancer. Biomark Res 2021;9:82. [PMID: 34742351 DOI: 10.1186/s40364-021-00338-0] [Reference Citation Analysis]
6 Jyotsana N, Ta KT, DelGiorno KE. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer. Front Oncol 2022;12:858462. [PMID: 35280777 DOI: 10.3389/fonc.2022.858462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang C, Liu N. Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer. Front Immunol 2022;13:920059. [DOI: 10.3389/fimmu.2022.920059] [Reference Citation Analysis]
8 Jin Y, Chen L, Li L, Huang G, Huang H, Tang C. SNAI2 promotes the development of ovarian cancer through regulating ferroptosis. Bioengineered 2022;13:6451-63. [DOI: 10.1080/21655979.2021.2024319] [Reference Citation Analysis]
9 Tan S, Kong Y, Xian Y, Gao P, Xu Y, Wei C, Lin P, Ye W, Li Z, Zhu X. The Mechanisms of Ferroptosis and the Applications in Tumor Treatment: Enemies or Friends? Front Mol Biosci 2022;9:938677. [DOI: 10.3389/fmolb.2022.938677] [Reference Citation Analysis]
10 Ke Y, Chen X, Su Y, Chen C, Lei S, Xia L, Wei D, Zhang H, Dong C, Liu X, Yin F. Low Expression of SLC7A11 Confers Drug Resistance and Worse Survival in Ovarian Cancer via Inhibition of Cell Autophagy as a Competing Endogenous RNA. Front Oncol 2021;11:744940. [PMID: 34790572 DOI: 10.3389/fonc.2021.744940] [Reference Citation Analysis]
11 Xu Z, Jiang S, Ma J, Tang D, Yan C, Fang K. Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment. Front Surg 2021;8:742360. [PMID: 34671639 DOI: 10.3389/fsurg.2021.742360] [Reference Citation Analysis]